Previous controversial reports have evaluated intertumoral heterogeneity, showing both discordance and concordance in the KRAS mutation status between the primary tumor and the matched metastases in patients with colorectal cancer [11, 13, 14]. The gene discussed is KRAS; the disease is neoplasm.